Physician profile
Paul Shepherd
NPI 1093918013
$623.23
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $76.86 · 2021: $25.19 · 2022: $38.04 · 2023: $124 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202 · Entertainment: $76.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.86 |
| Entertainment | $76.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.37 | 2019-2020 | |
| Alcon Vision LLC | $97.39 | 2019-2024 | Precision 1 |
| Coopervision INC. | $88.05 | 2022-2023 | Myday Contact Lens |
| Optos, INC. | $76.52 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $73.83 | 2022-2024 | Acuvue |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Biotissue Holdings INC. | $32.25 | 2019 | |
| Janssen Biotech, INC. | $21.58 | 2024 | Talvey, Tecvayli |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $16.62 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.